ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026)
ClearPoint Neuro (CLPT) reported Income from Continuing Operations of 9552000.0 for Q1 2026, down 58.51% on a YoY basis from 23024140.8 in Q1 2025, and down 23.2% sequentially from 7753000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Income from Continuing Operations data on file, last reported at 9552000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 58.51% year-over-year to 9552000.0; the trailing twelve-month figure through Mar 2026 stood at 29033000.0 (down 44.21% YoY), and the FY2025 full-year result was 25507000.0, down 39.75% from the prior year.
- Income from Continuing Operations declined to 9552000.0 in Q1 2026, from 7753000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 4146000.0 in Q1 2024 to a low of 14683000.0 in Q2 2022.
- A 5-year average of 7587000.0 and a median of 6026000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations surged 62.47% in 2024 and slumped 64.12% in 2025, its largest moves.
- Tracing CLPT's Income from Continuing Operations over 5 years: stood at 4641000.0 in 2022, then retreated by 5.47% to 4895000.0 in 2023, then increased by 3.49% to 4724000.0 in 2024, then plunged by 64.12% to 7753000.0 in 2025, then fell by 23.2% to 9552000.0 in 2026.
- Business Quant data shows CLPT's Income from Continuing Operations at 9552000.0 in Q1 2026, 7753000.0 in Q4 2025, and 5891000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -9.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.55 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -5.84 Mn |
| Mar 31, 2025 | -6.03 Mn |
| Dec 31, 2024 | -4.72 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.15 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -6.76 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.05 Mn |
| Dec 31, 2022 | -4.64 Mn |
| Sep 30, 2022 | -11.05 Mn |
| Jun 30, 2022 | -14.68 Mn |
| Mar 31, 2022 | -11.36 Mn |
| Dec 31, 2021 | -4.08 Mn |
| Sep 30, 2021 | -19.13 Mn |
| Jun 30, 2021 | -18.32 Mn |